Nexthera Capital as of March 31, 2017
Portfolio Holdings for Nexthera Capital
Nexthera Capital holds 35 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pfizer (PFE) | 13.7 | $27M | 785k | 34.21 | |
| Shire | 9.2 | $18M | 104k | 174.23 | |
| AstraZeneca (AZN) | 7.8 | $15M | 490k | 31.14 | |
| Celgene Corporation | 7.6 | $15M | 120k | 124.43 | |
| GlaxoSmithKline | 6.8 | $13M | 317k | 42.16 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 5.6 | $11M | 100k | 109.35 | |
| Alexion Pharmaceuticals | 5.3 | $11M | 87k | 121.24 | |
| Kite Pharma | 4.2 | $8.2M | 105k | 78.49 | |
| Tesaro | 3.9 | $7.7M | 50k | 153.88 | |
| Neuroderm Ltd F | 3.9 | $7.6M | 288k | 26.55 | |
| Global Blood Therapeutics In | 3.9 | $7.5M | 205k | 36.85 | |
| Vanda Pharmaceuticals (VNDA) | 3.7 | $7.2M | 512k | 14.00 | |
| Array BioPharma | 3.6 | $7.2M | 800k | 8.94 | |
| Minerva Neurosciences | 3.1 | $6.1M | 757k | 8.10 | |
| Newlink Genetics Corporation | 2.5 | $4.8M | 200k | 24.10 | |
| Cara Therapeutics (CARA) | 1.8 | $3.6M | 195k | 18.39 | |
| Aclaris Therapeutics (ACRS) | 1.7 | $3.3M | 112k | 29.82 | |
| Eiger Biopharmaceuticals | 1.5 | $3.0M | 264k | 11.45 | |
| Ignyta | 1.5 | $2.9M | 335k | 8.60 | |
| Paratek Pharmaceuticals | 1.5 | $2.9M | 150k | 19.25 | |
| Abeona Therapeutics | 1.3 | $2.5M | 494k | 5.00 | |
| Axsome Therapeutics (AXSM) | 0.8 | $1.6M | 400k | 3.90 | |
| Axovant Sciences | 0.8 | $1.5M | 100k | 14.94 | |
| Tigenix | 0.7 | $1.4M | 92k | 15.60 | |
| Marinus Pharmaceuticals | 0.7 | $1.4M | 800k | 1.77 | |
| Clearside Biomedical (CLSD) | 0.5 | $959k | 121k | 7.94 | |
| Zosano Pharma | 0.5 | $950k | 500k | 1.90 | |
| Advaxis | 0.4 | $791k | 97k | 8.17 | |
| Verastem | 0.3 | $696k | 336k | 2.07 | |
| Sierra Oncology | 0.3 | $612k | 400k | 1.53 | |
| Alkermes (ALKS) | 0.3 | $550k | 9.4k | 58.51 | |
| Obseva Sa | 0.3 | $521k | 50k | 10.42 | |
| Vistagen Therapeutics | 0.1 | $271k | 138k | 1.96 | |
| Vascular Biogenics | 0.1 | $183k | 33k | 5.49 | |
| Steadymed | 0.0 | $31k | 5.4k | 5.74 |
